Learn about the building blocks to educate and engage community providers in identification and referral to advanced therapies. Dr. Howie Tran, UC San Diego, will highlight real-world case studies that underscore the importance of timely referrals for advanced therapies, as well as review advancements in remote patient monitoring capabilities.
Watch RecordingHeart Failure Education Initiative
While there is no cure for HF, many people with this condition can live full, enjoyable lives and disease progression can be slowed. While people with early-stage HF often can manage their condition with lifestyle modifications and medications, more advanced therapies may be needed as the disease progresses. Yet, fewer than half of patients who may benefit from advanced HF specialty care ever receive it — a gap that particularly affects populations with limited access to health care resources
About 6.7 million American adults are living with HF, and prevalence is expected to reach more than 8 million by 2030.
The American Heart Association, a global force for healthier lives for all, has launched a new $3 million initiative, supported by Abbott, that aligns with the rising need for advanced treatment pathways and education beyond traditional guideline-directed medical therapy. This effort will provide cardiovascular clinicians with tools to support a growing HF population, including information on care models that connect specialists and clinical teams to improve patient outcomes.
Heart Failure Education Initiative Participating Sites
Multidisciplinary teams at each health system will engage in process mapping, expert collaboration and a national roundtable event.
Additional Resources for Health Care Professionals
Session 1: Remote Monitoring and Optimal Timing for Referral to a Heart Failure Specialist
Session 2: Bridging the Gap: Overcoming Barriers to Advanced Heart Failure Care in Rural Areas
Dr. Dmitry Yaranov, Baptist Memorial Hospital - Memphis, will explore the barriers to rural populations in receiving advanced heart failure specialty care, and provide innovative solutions and a model share on ways to overcome some of these barriers in care.
Watch RecordingSession 3: Substance Use and Advanced Heart Failure: Breaking Barriers to Advanced Care
This session will focus on understanding the prevalence of substance use in heart failure patients across the country and how it impacts patients’ eligibility for advanced heart failure therapies. Dr. Deborah Meyers, Oregon Health and Science University, will share how their program at OHSU is pioneering ways to implement fair and equitable policies to ensure these patients have opportunities to be evaluated for advanced therapy opportunities.
Session 4: Panel Q&A
Join Dr. Meyers and Dr. Yaranov as we lead a brief discussion about the future of advanced heart failure care and answer audience questions about advanced heart failure.
Sponsor
The American Heart Association’s Heart Failure Education Initiative is supported by Abbott.
